Not applicableEnded earlyNCT00773773
What this trial is testing
Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer
Who this might be right for
Prostate CancerElevated Prostate Specific Antigen (PSA)
Memorial Sloan Kettering Cancer Center 58